Neurokinin B is a paracrine vasodilator in the human fetal placental circulation

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 5, 2003, Pages 2164-2170

  Brownbill, Paul ^a   Bell, N J ^b   Woods, R J ^b   Lowry, P J ^b   Page, N M ^b   Sibley, C P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; N ACETYLTRYPTOPHAN 3,5 BIS(TRIFLUOROMETHYL)BENZYL ESTER; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR; NEUROKININ B; RECEPTOR SUBTYPE; SAREDUTANT; TACHYKININ; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ARTICLE; CONTROLLED STUDY; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; HYDROSTATIC PRESSURE; NERVE CELL; PLACENTA; PRIORITY JOURNAL; PROTEIN SECRETION; SYNAPSE; SYNCYTIOTROPHOBLAST; VASOCONSTRICTION; VASODILATATION;

BLOOD PRESSURE; BLOOD VESSELS; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; EPOPROSTENOL; FETUS; INDOMETHACIN; NEUROKININ B; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACENTA; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASODILATION;

MAMMALIA;

EID: 0038030795     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021727     Document Type: Article

References (52)

1. Nussdorfer GG, Malendowicz LK 1998 Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19:949-968
2. Regoli D, Drapeau G, Dion S, D'Orleans-Juste P 1987 Pharmacological receptors for substance P and neurokinins. Life Sci 40:109-117
3. Wagner U, Fehmann HC, Bredenbroker D, Yu F, Barth PJ, von Wichert P 1995 Galanin and somatostatin inhibition of neurokinin A and B induced airway mucus secretion in the rat. Life Sci 57:283-289
4. Regoli D, Nantel F 1991 Pharmacology of neurokinin receptors. Biopolymers 31:777-783
5. Page NM, Woods RJ, Gardiner SM, Lamthaisong K, Gladwell RT, Butlin DJ, Manyonda IT, Lowry PJ 2000 Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 405:797-800
6. Spivack M 1946 The anatomical peculiarities of the human umbilical cord and their clinical significance. Am J Obstet Gynecol 52:387-401
7. Page NM, Woods RJ, Lowry PJ 2001 A regulatory role for neurokinin B in placental physiology and pre-eclampsia. Regul Pept 98:97-104
8. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V 2002 The tachykinin peptide family. Pharmacol Rev 54:285-322
9. Emonds-Alt X, Doutremepuich JD, Heaulme M, Neliat G, Santucci V, Steinberg R, Vilain P, Bichon D, Ducoux JP, Proietto V, Broeck DV, Soubrie P, Fur GL, Breliere JC 1993 In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol 250:403-413
10. Lembeck F, Donnerer J, Tsuchiya M, Nagahisa A 1992 The non-peptide tachykinin antagonist, CP-96, 345, is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 105:527-530
11. Myatt L, Kossenjans W, Sahay R, Eis A, Brockman D 2000 Oxidative stress causes vascular dysfunction in the placenta. J Matern Fetal Med 9:79-82
12. Boura AL, Walters WA, Read MA, Leitch IM 1994 Autacoids and control of human blood flow. Clin Exp Pharmacol Physiol 21:737-748
13. MacLeod AM, Merchant KJ, Brookfield F, Kelleher F, Stevenson G, Owens AP, Swain CJ, Casiceri MA, Sadowski S, Ber E 1994 Identification of L-tryptophan derivatives with potent and selective antagonist activity at the NK1 receptor. J Med Chem 37:1269-1274
14. Kuo HP, Hwang KH, Lin HC, Wang CH, Liu CY, Lu LC 1998 Lipopolysaccharide enhances neurogenic plasma exudation in guinea-pig airways. Br J Pharmacol 125:711-716
15. Schneider H, Panigel M, Dancis J 1972 Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 114:822-828
16. Edwards D, Jones CJ, Sibley CP, Nelson DM 1993 Paracellular permeability pathways in the human placenta: a quantitative and morphological study of maternal-fetal transfer of horseradish peroxidase. Placenta 14:63-73
17. Brownbill P, Edwards D, Jones C, Mahendran D, Owen D, Sibley C, Johnson R, Swanson P, Nelson DM 1995 Mechanisms of α-fetoprotein transfer in the perfused human placental cotyledon from uncomplicated pregnancy. J Clin Invest 96:2220-2226
18. Chomczinski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
19. Page N, Butlin D, Manyonda I, Lowry P 2000 The development of a genetic profile of placental gene expression during the first trimester of pregnancy; a potential tool for identifying novel secreted markers. Fetal Diagn Ther 15:237-245
20. 4 receptor: a reappraisal. Eur J Pharmacol 437:27-30
21. Cascieri MA, Macleod AM, Underwood D, Shiao L-L, Ber E, Sadowski S, Yu H, Merchant KJ, Swain CJ, Strader CD, Fang TM 1994 Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor. J Biol Chem 269:6587-6591
22. Chang Y, Hoover DB, Hancock JC, Smith FM 2000 Tachykinin receptor subtypes in the isolated guinea pig heart and their role in mediating responses to neurokinin A. J Pharmacol Exp Ther 294:147-154
23. Nakada SY, Jerde TJ, Bjorling DE, Saban R 2001 In vitro contractile effects of neurokinin receptor blockade in the human ureter. J Urol 166:1534-1538
24. Firth JA, Leach L 1996 Not trophoblast alone: a review of the contribution of the fetal microvasculature to transplacental exchange. Placenta 17:89-96
25. Kaufmann P, Schroder H, Leichtweiss HP 1982 Fluid shift across the placenta. II. Fetomaternal transfer of horseradish peroxidase in the guinea pig. Placenta 3:339-348
26. Wilbur WJ, Power GG, Longo LD 1978 Water exchange in the placenta: a mathematical model. Am J Physiol 235:R181-R199
27. Brownbill P, Sibley CP 2001 U-46619 mediated vasoconstriction of fetal placental vasculature in the in vitro dually perfused human cotyledon - consequence on fetomaternal solvent transfer. J Soc Gynecol Investig 8(Suppl 1):142 (Abstract)
28. Grant AD, Akhtar R, Gerard NP, Brain SD 2002 Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms. J Physiol 543:1007-1014
29. Hoover DB, Chang Y, Hancock JC, Zhang L 2000 Actions of tachykinins within the heart and their relevance to cardiovascular disease. Jpn J Pharmacol 84:367-373
30. Shirahase H, Kanda M, Kurahashi K, Nakamura S 2000 Endothelium-dependent relaxation followed by contraction mediated by NK(1) receptors in precontracted rabbit intrapulmonary arteries. Br J Pharmacol 129:937-942
31. Mechiche H, Koroglu A, Elaerts J, Devillier P 2001 Vascular effects of neurokinins in humans. Therapie 56:205-211
32. Myatt L, Brewer A, Brockman DE 1991 The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164:687-692
33. Sladek SM, Magness RR, Conrad KP 1997 Nitric oxide and pregnancy. Am J Physiol 272:R441-R463
34. Holcberg G, Sapir O, Huleihel M, Katz M, Bashiri A, Mazor M, Malek A, Tsadkin M, Schneider H 2001 Indomethacin activity in the fetal vasculature of normal and meconium exposed human placentae. Eur J Obstet Gynecol Reprod Biol 94:230-233
35. Puschel G, Mentlein R, Heymann E 1982 Isolation and characterization of dipeptidyl peptidase IV from human placenta. Eur J Biochem 126:359-365
36. Hooper NM, Turner AJ 1985 Neurokinin B is hydrolysed by synaptic membranes and by endopeptidase-24.11 (enkephalinase) but not by angiotensin converting enzyme. FEBS Lett 190:133-136
37. Nau R, Schafer G, Deacon CF, Cole T, Agoston DV, Conlon JM 1986 Proteolytic inactivation of substance P and neurokinin A in the longitudinal muscle layer of guinea pig small intestine. J Neurochem 47:856-864
38. Skidgel RA, Erdos EG 1987 The broad substrate specificity of human angiotensin I converting enzyme. Clin Exp Hypertens A 9:243-259
39. Wang LH, Ahmad S, Benter IF, Chow A, Mizutani S, Ward PE 1991 Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme. Peptides 12:1357-1364
40. Giuliani S, Patacchini R, Barbanti G, Turini D, Rovero P, Quartara L, Giachetti A, Maggi CA 1993 Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors. J Pharmacol Exp Ther 267:590-595
41. Astolfi M, Treggiari S, Giachetti A, Meini S, Maggi CA, Manzini S 1994 Characterization of the tachykinin NK2 receptor in the human bronchus: influence of amastatin-sensitive metabolic pathways. Br J Pharmacol 111:570-574
42. Wang L, Sadoun E, Stephens RE, Ward PE 1994 Metabolism of substance P and neurokinin A by human vascular endothelium and smooth muscle. Peptides 15:497-503
43. Russell JS, Chi H, Lantry LE, Stephens RE, Ward PE 1996 Substance P and neurokinin A metabolism by cultured human skeletal muscle myocytes and fibroblasts. Peptides 17:1397-1403
44. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A 1993 Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87-146
45. Johnson AR, Skidgel RA, Gafford JT, Erdos EG 1984 Enzymes in placental microvilli: angiotensin I converting enzyme, angiotensinase A, carboxypeptidase, and neutral endopeptidase ("enkephalinase"). Peptides 5:789-796
46. Ino K, Suzuki T, Uehara C, Nagasaka T, Okamoto T, Kikkawa F, Mizutani S 2000 The expression and localization of neutral endopeptidase 24.11/CD10 in human gestational trophoblastic diseases. Lab Invest 80:1729-1738
47. Defendini R, Zimmerman EA, Weare JA, Alhenc-Gelas F, Erdos EG 1983 Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Neuroendocrinology 37:32-40
48. Imai K, Kanzaki H, Fujiwara H, Maeda M, Ueda M, Suginami H, Mori T 1994 Expression and localization of aminopeptidase N, neutral endopeptidase, and dipeptidyl peptidase IV in the human placenta and fetal membranes. Am J Obstet Gynecol 170:1163-1168
49. Mizutani S, Goto K, Nomura S, Ino K, Goto S, Kikkawa F, Kurauchi O, Goldstein G, Tomoda Y 1993 Possible action of human placental aminopeptidase N in feto-placental unit. Res Commun Chem Pathol Pharmacol 82:65-80
50. Hariyama Y, Itakura A, Okamura M, Ito M, Murata Y, Nagasaka T, Nakazato H, Mizutani S 2000 Placental aminopeptidase A as a possible barrier of angiotensin II between mother and fetus. Placenta 21:621-627
51. Gossrau R, Graf R, Ruhnke M, Hanski C 1987 Proteases in the human full-term placenta. Histochemistry 86:405-413
52. Parra MC, Lees C, Mann GE, Pearson JD, Nicolaides KH 2001 Vasoactive mediator release by fetal end othelial cells in intrauterine growth restriction and preeclampsia. Am J Obstet Gynecol 184:497-502